Behind the Bell: Nyxoah SA

Nyxoah SA CEO Olivier Taelman explains how the medtech company is creating innovative solutions to treat Obstructive Sleep Apnea (OSA), ensuring everyone can get a good night’s rest. 

Transcript: 
Chase your dream. I think that's important. And by also moving from private to public, that is already one step in that direction. 

We want to make sleep simple again. We want to offer millions of people a good night's rest when they are suffering from obstructive sleep apnea by offering them a cutting edge innovation technology where we stimulate the colossal nerve. It's very minimum invasive and no batteries. It's like a 60 minutes surgery. 

For us, Nasdaq represents innovation and opportunities. It gives you a lot of exposure to investors, and that gives us oxygen to focus on what our mission is. 

We invested in clinical data,in world-class evidence gathering, and we are now commercially available already in Europe, and on the verge of entering the US. 

Within five years from now, we would like to offer a smart, intelligent technology to all people suffering from obstructive sleep apnea.